Herriot Tabuteau (Chief Executive Officer) sold 49,666 shares of Axsome Therapeutics, Inc. (AXSM) at $240.25 per share, totaling approximately $11.93M.
Insider sales can be driven by various factors including portfolio diversification, tax obligations, or pre-arranged trading plans and do not necessarily reflect a negative outlook.